Akeso, Inc. (9926.HK) ("Akeso" or the "Company") announced that the first patient has been dosed in a Phase II clinical study (AK146D1-202) evaluating AK146D1, the Company's internally developed TROP2 ...

US research-peptide supplier scales its catalog against a market that analysts value between $47 billion and $141 billion, as ...

Using chatbots for therapy is becoming increasingly common, especially among young people, according to research ...

Wheaton Precious Metals (TSX:WPM) announced an 18% increase in its quarterly dividend alongside its Q2 results. The company ...

Sangfor aSV is now supported by Veeam Backup & Replication 13.1, enabling unified backup, recovery, and data protection for ...

Executive Chair George L. Holm recently exercised stock options and sold shares of Performance Food Group (PFGC) under a ...

Why GVS stock is in focus after fresh half year earnings GVS (BIT:GVS) is back on investors’ radar after reporting half year ...

Nakanishi (TSE:7716) has called a board meeting for 7 August 2026 to consider a two-for-one stock split of its common shares, ...

The Prime Minister’s summer tour follows his pledge on his first day in office to give the public ‘breathing space’ on bills.

Silence Therapeutics plc, (Nasdaq: SLN), a global clinical-stage company developing novel siRNA (short interfering RNA) ...

Darden Restaurants stock has produced a strong 77.5% return over the past five years, and at around US$213.76 per share the ...

Dividend and earnings update for Walker & Dunlop stock Walker & Dunlop (WD) has just paired a third quarter dividend ...